Designing Growth Strategies is in our DNA

Point-of-Care Coagulation (POCC) Testing Devices Market Size, Share & Industry Analysis, By Device Type (Anticoagulation Monitoring Devices {Prothrombin Time/International Normalized Ratio (PT/INR) Testing Devices, Activated Clotting Time (ACT), and Activated Partial Thromboplastin Time (aPPT)}, Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices {Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM)}, and Others), By End User (Hospitals & Clinics, Homecare Settings, and Others), and Regional Forecast, 2026-2034

Last Updated :July 2, 2026 | Format:PDF | Report ID: 101235

 

Request Sample PDF

man icon
Mail icon
Mail icon
What's included in this sample
Market segmentation:

Detailed and granular segments, regions and countries covered

Scope of research:

Comprehensive quantitative data and qualitative insights

Report structure:

Representation of data and insights in the report

Key findings:

Market Estimates, Growth Rate, Largest Region and Segment

Index:

Overview of data and insights in each chapter

Research Methodology:

Summary of research processes adopted

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 140